No Detail Found!

Coronary intervention and clopidogrel resistance –a local experience.

Author(s)
Bilal S. Mohydin Department of Cardiology, Punjab Institute of Cardiology, Lahore, Pakistan
Faiza Bashir Hematology Section, Department of Pathology, Services Institute of Medical Sciences, Lahore, Pakistan
Sajjad Ahmad Department of Cardiology, Punjab Institute of Cardiology, Lahore, Pakistan
Ayesha Hameed Hematology Section, Chughtai’s Lahore Lab, Lahore, Pakistan
Shabana Azim Hematology Section, Chughtai’s Lahore Lab, Lahore, Pakistan
Bilal Zakariah Khan Department of Cardiology, Punjab Institute of Cardiology, Lahore, Pakistan
Abstract
BACKGROUND: Dual antiplatelet therapy (DAP) is the cornerstone managing coronary artery : disease in the current era of coronary interventions. The pattern of resistance to Clopidogrel. in our population is not known. The objective of this study was to assess the frequency of resistance / hypo-responsiveness to Clopidogrel after percutaneous coronary intervention (PCI) in Pakistani population. METHODS: The study was done at : Punjab Institute of Cardiology over a period of 5 months in 2012-13. After informed consent, patients who underwent PCI 4 weeks earlier were enrolled. All patients had recieved 600mg of Clopidogrel 4 to 6 hours before PCI and were taking Aspirin 75mg and Clopidogrel 75mg twice daily in addition to their routine medicine. Venous blood samples of all selected patients were collected and P2Y12 blockade analysis test was performed. The test has a “Closure Time” measured in seconds. Patients were labelled, on the basis of this Time, as resistant (closure time 225 seconds). Demographic data and coronary risk factors wre noted for all patients. Results: Results: Fifty patients (38 men and 12 women) were studied Results:. Fifteen (30%) patients were. resistant to Clopidogrel, 5 (10%) were hyporespnsive and 30 (60%) were fully responsive as per closure time criteria. None of them suffered a clinically evident coronay event during 4 weeks post PCI. CONCLUSION: More than 1/3rd of our post PCI patients are likely to be resistant or hypo- : responsive to Clopidogrel.
Publication Details
Page(s) 14-18
DOI DOI not available
Published Journal: Journal of Cardiovascular Diseases, Volume: 11, Issue: 1, Year: 2013

Request the full text from PASTIC

0

Citations

0

Downloads

65

Views